Skip to main content
. 2021 Apr 6;10(7):1525. doi: 10.3390/jcm10071525
HPVs Human papillomaviruses
CEC cervical cancer
OPC oropharyngeal cancer
ct-DNA Circulating tumor DNA
PCR polymerase chain reaction
ddPCR digital droplet-based PCR
HR high-risk
ISH in situ hybridization
TA-4 tumor associated antigen 4 (the squamous cell carcinoma antigen)
CEA Carcino Embryonic Antigen
TPA Tissue Polypeptide Antigen
TPS Tissue Polypeptide Specific Antigen
CYFRA 21-1 cytokeratin-19 fragments
HNSCC head and neck squamous cell cancer
cf-DNA cell-free DNA
ct-DNA cell-free tumoral DNA
NPC nasopharyngeal carcinoma
HPV ct-DNA circulating HPV DNA
HPV16 ct-DNA circulating tumor HPV16 DNA
AUC area under the curve
dPCR digital PCR
NGS next generation sequencing
TIL tumor infiltrating lymphocyte therapy
EBV Epstein-Barr Virus
ASCC anal squamous cell carcinoma
CNVs copy number variation